The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. What Are ...
You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on 02/05/2001. An increasingly popular option among retail and institutional investors ...
iShares Biotechnology ETF earns an Average Process Pillar rating. Morningstar's algorithmically assigned Passive Process ratings are first formulated by comparing the historical efficacy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback